Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. [electronic resource]
Producer: 20140717Description: 577-89 p. digitalISSN:- 1916-7075
- Adrenergic beta-Antagonists -- therapeutic use
- Adult
- Aortic Dissection -- prevention & control
- Aneurysm, False -- surgery
- Aneurysm, Ruptured -- complications
- Angiotensin Receptor Antagonists -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Aorta, Thoracic -- abnormalities
- Aortic Aneurysm, Thoracic -- genetics
- Aortic Valve -- surgery
- Automobile Driving
- Cardiac Catheterization
- Coronary Artery Disease -- prevention & control
- Decision Making
- Diagnostic Imaging
- Diet
- Ehlers-Danlos Syndrome -- complications
- Endovascular Procedures
- Exercise
- Female
- Genetic Testing
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypertension -- drug therapy
- Life Style
- Loeys-Dietz Syndrome -- complications
- Marfan Syndrome -- diagnosis
- Patient Care Team
- Patient Selection
- Pregnancy
- Preoperative Care
- Quality Assurance, Health Care
- Risk Assessment
- Smoking Cessation
- Stents
- Turner Syndrome -- complications
No physical items for this record
Publication Type: Journal Article; Practice Guideline; Review
There are no comments on this title.
Log in to your account to post a comment.